Resumen

PEREZ RUIZ, Leslie; COLLAZO HERRERA, Manuel  y  IZNAGA-ESCOBAR, Normando. The relevance of the pharmacoeconomics to clinical trials with biotech products. Rev. colomb. cienc. quim. farm. [online]. 2014, vol.43, n.1, pp.120-136. ISSN 0034-7418.  https://doi.org/10.15446/rcciquifa.v43n1.45468.

Objective: To assess the importance of the introduction of economic evaluation studies in the development of clinical trials with biotechnology drugs. Methods: A literature review was conducted in order to argue the value of incorporating pharmacoeconomic studies in the different phases of a biotech product development as a key element in the search for efficiency in decision-making in the Biopharmaceutical industry and the National Health System. Results: The insertion of the pharmacoeconomic studies in the clinical trial with biotech drugs is very important, because they will permit to know if the drug is efficient or not, their inclusion in the drug scheme, their price, as well as, to compare it with the different therapeutic alternatives available in the market and to determine the therapeutic options that should use in routine medical practice and maximize the opportunities that these new innovative drugs can offer. Conclusions: The inclusion of pharmacoeconomic studies in the development of biotech product will enable increased the efficiency, as well as, to prioritize and allocate the necessary resources of Biopharmaceutical industry to the therapeutic options with greatest economic and social advantages.

Palabras clave : Pharmacoeconomics; Efficiency; Biotechnology drugs; Clinical trials.

        · resumen en Español     · texto en Español     · Español ( pdf )